General Information of the Compound
Compound ID
CP0194799
Compound Name
4-(3-aminophenyl)-1,2-dimethyl-5-(quinoxalin-6-yl)-1H-pyrazol-3(2H)-one
    Show/Hide
Structure
Formula
C19H17N5O
Molecular Weight
331.379
Canonical SMILES
Cn1c(c(-c2cccc(N)c2)c(=O)n1C)-c1ccc2nccnc2c1
    Show/Hide
InChI
InChI=1S/C19H17N5O/c1-23-18(13-6-7-15-16(11-13)22-9-8-21-15)17(19(25)24(23)2)12-4-3-5-14(20)10-12/h3-11H,20H2,1-2H3
    Show/Hide
InChIKey
DHZPFNWYOKQHND-UHFFFAOYSA-N
Physicochemical Property
logP
2.5832
Rotatable Bonds
2
Heavy Atom Count
25
Polar Areas
78.73
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16730830
SID: 26688993
ChEMBL ID
CHEMBL603851
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01221, TGF-beta receptor type-1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000063 Hep-G2 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS